Within the Council’s purview are (1) the benefits and risks of drug products, (2) evidence-based use of medicines, (3) the application of drug information in practice, and (4) related matters.
2023-2024 Term
| Name | Position | State |
| Russel Roberts | Chair | Massachusetts |
| Kate Ward | Vice Chair | Nevada |
| Scott Bolesta | Member | Pennsylvania |
| Rachel Bubik | Member | Minnesota |
| Jerika Lam | Member | California |
| Zahra Nasrazadani | Member | Kansas |
| Kunal Patel | Member | Georgia |
| Martha Roberts | Member | Rhode Island |
| David Silva | Member | Connecticut |
| Thomas Szymanski | Member | West Virginia |
| Brittany Tschaen | Member | Delaware |
| Frank Diaz | Technician | California |
| Simran Chahal | Student | Tennessee |
| Vickie Powell | Board Liaison | New York |
| Vicki Basalyga | Secretary | Maryland |
